Accolate Drug Interactions
Currently displaying 250 drugs known to have a moderate interaction with Accolate (zafirlukast).
Moderate interactions with Accolate (zafirlukast)
Note: Showing generic names only.
A
- acalabrutinib
- adagrasib
- adalimumab
- ado-trastuzumab emtansine
- alfentanil
- alpelisib
- aminophylline
- amiodarone
- anisindione
- aprepitant
- aripiprazole
- asciminib
- asparaginase erwinia chrysanthemi
- asparaginase escherichia coli
- aspirin
- atazanavir
- atorvastatin
- auranofin
- aurothioglucose
- avacopan
- avapritinib
- axitinib
B
- bedaquiline
- benznidazole
- black cohosh
- bortezomib
- bosentan
- bosutinib
- brentuximab
- brigatinib
- bromocriptine
- budesonide
- budesonide nasal
- buprenorphine
C
- cabazitaxel
- calaspargase pegol
- cannabidiol
- capivasertib
- carboplatin
- carfilzomib
- cariprazine
- celecoxib
- ceritinib
- cerivastatin
- certolizumab
- cevimeline
- chloramphenicol
- chloroquine
- cilostazol
- cisplatin
- clofarabine
- cobimetinib
- colchicine
- crizotinib
D
- dabrafenib
- daclizumab
- dapsone
- daridorexant
- darifenacin
- dicumarol
- didanosine
- dihydroergotamine
- dinutuximab
- disulfiram
- docetaxel
- dofetilide
- dronedarone
- drospirenone
- duvelisib
E
- efavirenz
- eletriptan
- eliglustat
- elotuzumab
- elranatamab
- enfortumab vedotin
- entrectinib
- enzalutamide
- epirubicin
- ergonovine
- ergotamine
- eribulin
- erythromycin
- etanercept
- ethambutol
- ethionamide
- etoposide
- etranacogene dezaparvovec
- etravirine
- everolimus
F
- fedratinib
- fenofibrate
- fentanyl
- fesoterodine
- fidanacogene elaparvovec
- finerenone
- flibanserin
- fludarabine
- fluvastatin
- fosaprepitant
- fostamatinib
G
H
I
- idelalisib
- imatinib
- infigratinib
- infliximab
- interferon alfa-2a
- interferon alfa-2b
- interferon alfa-n1
- interferon alfacon-1
- interferon beta-1a
- interferon beta-1b
- iodoquinol
- ipilimumab
- irinotecan
- irinotecan liposomal
- isoniazid
- ivabradine
- ivacaftor
- ivosidenib
- ixabepilone
- ixazomib
L
- lapatinib
- larotrectinib
- lefamulin
- lesinurad
- letermovir
- levodopa
- linezolid
- lorlatinib
- lovastatin
- lumateperone
- lurasidone
- lurbinectedin
M
- maraviroc
- mavacamten
- mavorixafor
- methotrexate
- methylergonovine
- methysergide maleate
- metronidazole
- midostaurin
- mifepristone
- mirvetuximab soravtansine
- mobocertinib
- montelukast
- mosunetuzumab
N
O
P
- paclitaxel
- paclitaxel protein-bound
- palbociclib
- palovarotene
- panobinostat
- pazopanib
- pegaspargase
- peginterferon alfa-2a
- peginterferon alfa-2b
- peginterferon beta-1a
- pemigatinib
- pimavanserin
- pitavastatin
- polatuzumab vedotin
- pomalidomide
- ponatinib
- pralsetinib
- pravastatin
R
- red yeast rice
- remdesivir
- repaglinide
- repotrectinib
- ribociclib
- rifampin
- rifapentine
- rilpivirine
- ripretinib
- roflumilast topical
- rosuvastatin
- rucaparib
S
- saxagliptin
- secnidazole
- selinexor
- selpercatinib
- selumetinib
- sildenafil
- silodosin
- simvastatin
- solifenacin
- sonidegib
- sparsentan
- stavudine
- stiripentol
T
- tadalafil
- talquetamab
- tarlatamab
- tazemetostat
- teclistamab
- telbivudine
- temsirolimus
- teniposide
- tepotinib
- thalidomide
- theophylline
- thioguanine
- tinidazole
- tisotumab vedotin
- tocilizumab
- tolterodine
- toremifene
- torsemide
- trabectedin
- tramadol
- tucatinib
U
V
- valdecoxib
- valoctocogene roxaparvovec
- vardenafil
- venetoclax
- vinblastine
- vincristine
- vincristine liposome
- vinorelbine
- voriconazole
W
Z
Accolate alcohol/food interactions
There is 1 alcohol/food interaction with Accolate (zafirlukast).
Accolate disease interactions
There is 1 disease interaction with Accolate (zafirlukast) which include:
More about Accolate (zafirlukast)
- Accolate consumer information
- Check interactions
- Compare alternatives
- Reviews (4)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: leukotriene modifiers
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.